iTeos Therapeutics, Inc. (ITOS)
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Address
321 ARSENAL STREET
WATERTOWN, MA 02472
Founded
2012
Number of Employees
173
Website
http://www.iteostherapeutics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at ITOS make a trade.
Creating a free account takes less than one minute